New York – United States
The Liquid Biopsy Market is expected to grow in the forecast year due to the rise in market players and the availability of advanced services. Along with this, manufacturers are engaged in the developmental activity for launching novel services in the market. The increasing development in the field of advanced healthcare techniques is further boosting market growth.
However, difficulties such as the lack of standardized protocols and the lack of skilled professionals might hamper the growth of the global liquid biopsy market in the forecast period.
Data Bridge Market Research analyzes that the global liquid biopsy market will grow at a CAGR of 15.2% during the forecast period of 2023 to 2030.
The increasing awareness of advanced diagnostic technology globally has enhanced the demand for the market. The rising healthcare expenditure for better health services also contributes to the market’s growth. The major market players focus on various service launches and approvals during this crucial period. In addition, the increase in improved advancement of processes and techniques also contributes to the rising demand for liquid biopsy.
Download an Exclusive Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-liquid-biopsy-market&dv
Some of the major players in the global liquid biopsy market are F. Hoffmann-La Roche Ltd, Guardant Health, Thermo Fisher Scientific Inc., Exact Sciences Corporation (Genomic health), QIAGEN, Labcorp, Johnson & Johnson Services, Inc., Illumina Inc, mdxhealth, NeoGenomics Laboratories, Bio-Rad Laboratories, Inc., Natera, Inc., CARDIFF ONCOLOGY, INC., PathAI, STRECK, Menarini Silicon Biosystems, Biocept, Inc., Sysmex Inostics Inc., Fluxion Biosciences Inc, Epic Sciences, Predicine, ANGLE plc, and Oncocyte Corporation among others.
Global Liquid Biopsy Market Scope
The global liquid biopsy market is categorized into nine notable segments which are product, Biomaker type, sample type, analytical type, application type, clinical application, technology, end user, and distribution channel. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Instruments
- Consumables & Accessories
- Services & Software
On the basis of product, the market is segmented into instruments, consumables & accessories, services & software.
Biomaker Type
- Circulating Tumor Cells (CTCS)
- Circulating Cell-Free DNA (CFDNA)
- Cell-Free RNA
- Exosomes
- Extracellular vesicles
- Others
On the basis of biomaker type, the market is segmented into circulating tumor cells (CTCS), circulating cell-free DNA (CFDNA), cell-free RNA, extracellular vesicles, exosomes, and others.
Sample Type
- Blood Sample-Based
- Urine Sample-Based
- Saliva & Other Tissue Fluids Sample-Based
- Others
On the basis of sample type, the market is segmented into blood sample-based, urine sample-based, saliva & other tissue fluid sample-based, and others.
Analytical Type
- Molecular
- Proteomic
- Histology/Imaging
On the basis of analytical type, the market is segmented into molecular, proteomics, and histology/imaging.
Application Type
- Cancer Applications
- Non-Cancer Applications
On the basis of application type, the market is segmented into cancer applications and non-cancer applications.
Clinical Application
- Routine Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
- Patient Work-Up
- Others
On the basis of clinical application, the market is segmented into routine screening, patient work-up, therapy selection, treatment monitoring, recurrence monitoring, and others.
Technology
- Multi-Gene-Parallel Analysis
- Single Gene Analysis
On the basis of technology, the market is segmented into multi-gene parallel analysis and single-gene analysis.
End User
- Hospitals
- Reference Laboratories
- Diagnostics Centers
- Research Centres and Academic Institutes
- Others
On the basis of end user, the market is segmented into hospitals, reference laboratories, diagnostic centers, research centers & academic institutes, and others.
Distribution Channels
- Direct Tender
- Third Party Distributor
- Others
On the basis of distribution channel, the market is segmented into direct tender, third party distributor, and others.
Get a Comprehensive Understanding of This Research Report @ https://www.databridgemarketresearch.com/reports/global-liquid-biopsy-market?dv
Thank you for dedicating your time to reading this article. If you’re interested in delving deeper into specific chapters or regional reports, such as North America, Europe, or Asia, we invite you to visit our website. There, you will find a wealth of valuable information waiting to be explored.
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience, which was formulated and framed in the year 2015 in Pune.
Media Contact
Sopan Gedam
Organization: Data Bridge Market Research
Phone: +1-888-387-2818
Email: sales@databridgemarketresearch.com
Web: www.databridgemarketresearch.com